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The Kennedy KMeger Institute and Department ofPsychiatry, Johns Hopla’ns University, Baltimore, MD
and the Department ofPsychiatry3, Harvard University, Boston, MA, USA
Individuals with trisomy, most prominently
among them, Down’s Syndrome, present with
abnormal brain development and mental re-
tardation. Whether such abnormal brain devel-
opment is the consequence of enhanced levels of
expression of all triplicated genes or the result of
altered expression of certain developmentally
important genes has long been unclear. Trisomy
of mouse chromosome 16[Ts16] shares pheno-
typic and genotypic similarities with human tri-
somy 21, Down’s Syndrome [DS], thus providing
a suitable model to address the mechanism by
which gene imbalance may affect brain on-
togeny. However, Ts16 does not survive past late
gestation. We chose transplantation of late
embryonic Tsl6 cortex into neonatal euploid
hosts as a paradigm to examine later stages of
forebrain development. Previous results with
somatostatin and GAP-43, both located on
chromosome 16, showed expression patterns
that were specific to the transplant age and
mostly differed from the host /2/. However,
unlike Ts16 embryos, Ts16 grafts did not show
elevated expression of genes located on chromo-
some 16 if compared to euploid, age matched
grafts and/or host cortex. Thus, host and graft
tissue appeared to interact with each other in
regulating the expression of genes located on
chromosome 16.
This study investigates the expression of APP
peptides and mRNA in grafts of late embryonic
Ts16 and euploid litter mate cortex transplanted
to the neocortex of neonatal euploid hosts. At all
ages, both Tsl6 and euploid grafts display some
intensely APP immunoreactive [IR] cellular
structures of unusual morphology near their
borders with the host cortex. These may repre-
sent a glial response to transplantation "injury".
Aside from these structures, APP-IR is compa-
rable in both pattern and intensity in both Ts16
and euploid grafts as well as in host tissue at
postnatal day [PND] 7 after transplantation. In
contrast, by PND 14 a "halo" of diffuse IR is
present in and around the grafts; this is particu-
larly apparent in the Ts16 grafts. This localized
elevation in IR is transient and can no longer be
observed in cases one month post-transplanta-
tion and older. However, many of the hosts car-
rying Ts16 transplants begin to show a severely
disrupted pattern of IR in the CA3 region of the
hippocampus. Similar pathology was observed
previously by us in host animals following the
grafting of PC12 cells transformed with the
carboxy-terminal 105 amino acids of APP. These
APP-IR changes in the host hippocampus re-
semble the effects of intraventricular excitatory
amino acid injections in the adult rodents/1,5/,
with the exception that adjacent Nissl stained
sections did not show neuronal loss.
Expression ofmRNA for APP, as analyzed by
in situ hybridization, shows an age dependent
pattern in both Ts16 and euploid graft that
differs from the host cortex. As in the IR
pattern, a transient elevation is observed in both
Ts16 and euploid transplants at PND 14 with
younger and older grafts exhibiting below host
levels of mRNA expression. Expression is the
lowest in aged grafts, 1 year after transplan-
tation, for both Ts16 and euploid. Thus, unlike
in the Ts16 embryos/1/, APP mRNA is not gen-
erally elevated above euploid levels in the Ts16
grafts. However, preliminary results suggest
differences in the time course and levels of APP
mRNA expression in Ts16 vs. euploid grafts
when expression is measured as percentage of
host cortex.
The current results are compatible with the
notion that APP is a developmentally regulated
(C) FREUND PUBLISHING HOUSE LTD., LONDON. JOURNAL OFNEURALTRANSPLANTATION & PLASTICITY, Vol. 3, No. 4, 1992329
signal sequence
cysteine rich region
negatively charged region
N-glycosylation site region
B-amyloid peptide
transmembrane segment
cytoplasmic domain
Reagents:
F1 and B5 antibodies showed comparable
staining patterns in BALB/cByJ mice.
F1 was used for the present study.
The cDNA shown below was used for
in situ hybridization experiments
insert
6666666dd
B5 antibodies
CHO CHO
coding sequence
non-coding sequence
F5 antibodies
/ COOH
/
/
/
/
/
/
5’ I,IIIi11111111111111111111111111111111111111111
C DNA
,3’
gene with a role in cortical morphogenesis. The
data support previous results with transplants of
PC12 cells expressing an APP peptide /3/ which
show that abnormal levels of APP peptide ex-
pression (C104) during development can lead to
hippocampal pathologies as the animal matures.
However, unlike some other investigators, we
have failed to observe age dependent patho-
morphology or amyloid formation directly
associated with the Ts16 grafts or surrounding
host cortex. Finally, as seen for SOM and GAP-
433, APP protein and mRNA expression appear
to be regulated in the grafts in ways that differ
from normal development but are not primarily
a function of gene dosage.
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